We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As a growing number of studies raise alarms about using hydroxychloroquine to treat COVID-19, the National Institutes of Health (NIH) is starting a large clinical trial to evaluate the drug in combination with the antibiotic azithromycin. Read More
FDA drug approvals were down 16 percent in 2019 compared with 2018, a reduction that predates the COVID-19 outbreak, according to data and analytics firm GlobalData. Read More
A California appeals court has ruled that hundreds of Risperdal-related cases against Johnson & Johnson and its subsidiaries may proceed, reversing a decision that had dismissed the pending cases. Read More
The FDA is working with the Centers for Disease Control and Prevention (CDC) to determine how it will restart routine on-site inspections of drug manufacturing facilities, the agency has announced. Read More
The World Health Organization (WHO) said this week that “potentially positive data” is coming out of early clinical trials of COVID-19 treatments, but it declined to name the specific drugs showing promise. Read More
Oxford University has launched a clinical trial testing existing drugs, including hydroxychloroquine and azithromycin, as preventative COVID-19 treatments in older patients. Read More